Skip to main content
Log in

BG-104 enhances the decreased plasma superoxide scavenging activity in patients with Behçet's disease, Sjögren's syndrome or hematological malignancy

  • Published:
Biotherapy

Summary

BG-104, a compound of Chinese herbs, has been reported to exert superoxide scavenging activity (SSA) in cell free systems. This report addressesin vivo effects of BG-104 in various disorders. The plasma SSA and laboratory parameters were determined in patients Behçet's disease (BD), Sjögren's syndrome (SjS) or hematological malignancy (M), and the effects of BG-104 treatment on these parameters were studied and compared with those of another antioxidant, vitamin E (alpha-tocopherol).

The plasma SSA was significantly lower both in patients with BD and M, and in patients with SjS without antioxidant treatment as compared to that in healthy controls, and it showed an inverse correlation with disease activities. The treatment with BG-104 and/or vitamin E significantly enhanced the plasma SSA in all disorders studied. Both the erythrocyte sedimentation rates, the absolute number of neutrophils, as well as C-reactive protein levels were significantly lower in patients treated with BG-104 and/or vitamin E than those without these drugs. These results indicate that the BG-104 has an anti-inflammatory effect through enhancing plasma SSA in patients with BD, SjS or M.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Auto-oxidative damage in Beçhet's disease — endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982; 49: 247–55.

    PubMed  Google Scholar 

  2. Harris ED. Pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders Co, 1985: 886–914.

    Google Scholar 

  3. Kensler TW, Bush DM, Kozumbo WJ. Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 1983; 221: 75–81.

    PubMed  Google Scholar 

  4. Mizushima H. Recent research into Bechet's disease in Japan. Int J Tiss Reac 1988; 10: 59–65.

    Google Scholar 

  5. Goebel KM, Herbert V, Storck U. Clinical and intrasynovial efficacy of orgotein treatment in rheumatoid arthritis of knee joints. In: Greenwald RA, Cohen G, eds. Oxy radicals and their scavenger systems, cellular and medical aspects, Vol II. New York: Elsevier, 1983: 255–67.

    Google Scholar 

  6. Santavuori P, Heiskala H, Westmark T, Sainio K, Moren R. Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren's disease. Am J Med Genet 1988; 5: 265–74.

    Google Scholar 

  7. Greenwald RA. Therapeutic benefits of oxygen radical scavenger treatments remain unproven. Free Rad Biol Med 1985; 1:173–7.

    Google Scholar 

  8. Huber W, Saifer MGP. Orgotein, The drug version of bovine Cu-Zn superoxide dismutase. I. A summary account of safety and pharmacology in laboratory animals. In: Michelson AM, McCord JM, Fridovich I, eds. Superoxide and superoxide dismutases. London: Academic Press, 1977: 517–21.

    Google Scholar 

  9. Niwa Y. Investigation of the drug delivery system (DDS) in natural medicinal or health products — clinical effectiveness and inhibitory effect of lipid peroxidation of SOD-like health products and cancer retardant effect of natural product BG-104. Pharm Tech Japan 1987; 3: 1067–81. (in Japanese)

    Google Scholar 

  10. Niwa Y. Action mechanism of Chinese herbs, BG-102, 103 and 104 with special reference to their effects on membrane phospholipid enzyme activities of human leukocytes and oxygen radicals generated. Jpn J Inflammation 1987; 7: 367–75. (in Japanese)

    Google Scholar 

  11. Prónai L, Arimori S, Nakazawa H. Superoxide scavenging activity of BG-104 before and after sonication — determined by ESR spin trapping method. Biotherapy 1990; 2: 63–8.

    PubMed  Google Scholar 

  12. Prónai L, Arimori S. Effect of vitamin-E on decreased plasma superoxide scavenging activity in Sjögren's syndrome. In: Research Committee of Vitamin, eds. Progress in research of vitamin-E. Tokyo: Eido Publ. 1990: 90–6.

    Google Scholar 

  13. Niwa Y, Kanoh T, Kasama T, Negishi M. Activation of antioxidant activity in natural medicinal products by heating, brewing and lipophilization. A new drug delivery system. Drugs Exptl Clin Res 1988; 14: 361–72.

    Google Scholar 

  14. Lowry OH, Rosenbrough NJ, Farr AL, Ranadall BJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75.

    PubMed  Google Scholar 

  15. Farell PM. Human health and disease: a deficiency state, pharmacological effects and nutrition requirements. In: Mechlin LJ, ed. Vitamin E. Tokyo: Academic Press, 1980: 519–620.

    Google Scholar 

  16. Umeki S, Sumi M, Niki Y, Soejima R. Concentrations of superoxide dismutase and superoxide anion in blood of patients with respiratory infections and compromised immune systems. Clin Chem 1987; 33: 2230–3.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prónai, L., Arimori, S. BG-104 enhances the decreased plasma superoxide scavenging activity in patients with Behçet's disease, Sjögren's syndrome or hematological malignancy. Biotherapy 3, 365–371 (1991). https://doi.org/10.1007/BF02221330

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02221330

Key words

Navigation